# Immunoglobulin G Therapy Dose Optimization

> **NCT04818177** · — · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 40 (actual)

## Conditions studied

- Obesity
- Immune Deficiency

## Interventions

- **DRUG:** Institutional standard intravenous immune globulin treatment

## Key facts

- **NCT ID:** NCT04818177
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818177, "Immunoglobulin G Therapy Dose Optimization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04818177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*